Deep cervical lymphatic–venous anastomosis attenuates cognitive dysfunction and biomarker abnormalities in severe Alzheimer's disease: A prospective single‐arm study
Alzheimer's & Dementia · 2026-02 · 22 (2)
DOI: 10.1002/alz.71150 ↗Kurz gefasst
Fachartikel in der Zeitschrift Alzheimer's & Dementia, online erschienen am 03.02.2026. Verfasst von Xiaohong Fu und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, The Third Affiliated Hospital of Zunyi Medical University (The First People's Hospital of Zunyi), Zunyi, Guizhou Province…. Hauptthemen laut MEDLINE: Alzheimer Disease, Anastomosis, Surgical, Cognitive Dysfunction, Lymphatic Vessels. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Key Projects of Guizhou Provincial Health and High-quality Development Medical Research Joint Fund, Guizhou Provincial Higher Education Science and Technological Innovation Team, Guizhou High-level (BAI) Innovative Talents Project.
Themen: Demenz
Abstract (Originalsprache)
INTRODUCTION This study evaluated the efficacy of deep cervical lymphatic–venous anastomosis (dcLVA) for severe Alzheimer's disease (AD). METHODS A total of 139 severe AD patients undergoing dcLVA were enrolled, and changes in cognitive function and biomarkers were evaluated by comparing preoperative measures with postoperative outcomes over a 6‐month follow‐up period. RESULTS Patients undergoing dcLVA showed modestly elevated Mini‐Mental State Examination (MMSE) scores from 48 hour postoperatively to 6‐month follow‐up. At 6‐month, observable changes across functional status and neuropsychiatric symptoms were documented, as demonstrated by reductions in scores on the Activities of Daily Living (ADL) scale, Neuropsychiatric Inventory (NPI), Neuropsychiatric Inventory‐Caregiver Distress (NPI‐D), and Sleep Disorders Inventory (SDI). Biomarker analyses revealed decreased cerebrospinal fluid (CSF) β‐amyloid (Aβ) 42, Aβ40, and p‐Tau levels postoperatively, along with increased plasma concentrations of these markers. No deaths or serious procedure‐related adverse events occurred during 6‐month follow‐up. DISCUSSION These findings suggest that dcLVA may confer multifaceted clinical benefits in severe AD patients, including attenuation of certain neuropsychiatric dysfunctions and a potential slowing of symptom progression.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurosurgery, The Third Affiliated Hospital of Zunyi Medical University (The First People's Hospital of Zunyi), Zunyi, Guizhou Province, China.
- Department of Anesthesiology, The Third Affiliated Hospital of Zunyi Medical University (The First People's Hospital of Zunyi), Zunyi, Guizhou Province, China.
- Department of Anesthesiology, West China Tianfu Hospital, Sichuan University, Chengdu, Sichuan Province, China.
- Department of TCM, The Third Affiliated Hospital of Zunyi Medical University (The First People's Hospital of Zunyi), Zunyi, Guizhou Province, China.
- State Key Laboratory of Biotherapy, Department of Radiology, Huaxi MR Research Center (HMRRC), Institution of Radiology and Medical Imaging, West China Hospital of Sichuan University, Sichuan University, Chengdu, Sichua…
- Department of Laboratory Medicine / Scientific Research Center, The Third Affiliated Hospital of Zunyi Medical University (The First People's Hospital of Zunyi), Zunyi, Guizhou Province, China.
Förderung
- Key Projects of Guizhou Provincial Health and High-quality Development Medical Research Joint Fund
- Guizhou Provincial Higher Education Science and Technological Innovation Team
- Guizhou High-level (BAI) Innovative Talents Project
- 2025 National Key Clinical Specialty Construction Project (Clinical Laboratory)
- Guizhou Province Distinguished Young Scientific and Technological Talent Program
- Zunyi Medical University 12345 Future Talent Training Program-Technology Elite
- Talent Research Startup Fund from the First People's Hospital of Zunyi (to Liu-Lin Xiong)
Zitieren
APA
Fu, X., Zhang, J., Xiao, Q., Li, T., Li, Q., Zhang, S., Zeng, W., Gong, M., Cai, P., Deng, Z., Zhang, X., Xin, Y., Su, L., Tian, X., Wu, K., & Xiong, L. (2026). Deep cervical lymphatic–venous anastomosis attenuates cognitive dysfunction and biomarker abnormalities in severe Alzheimer's disease: A prospective single‐arm study. Alzheimer's & Dementia, 22(2). https://doi.org/10.1002/alz.71150
Vancouver
Fu X, Zhang J, Xiao Q, Li T, Li Q, Zhang S, et al. Deep cervical lymphatic–venous anastomosis attenuates cognitive dysfunction and biomarker abnormalities in severe Alzheimer's disease: A prospective single‐arm study. Alzheimer's & Dementia. 2026;22(2). doi:10.1002/alz.71150
BibTeX
@article{Fu2026,
author = {Fu, Xiaohong and Zhang, Jing and Xiao, Qiuxia and Li, Tingting and Li, Qijun and Zhang, Shaofu and Zeng, Wen and Gong, Min and Cai, Pan and Deng, Zhaojian and Zhang, Xuan and Xin, Yuanjun and Su, Liping and Tian, Xiaohe and Wu, Kaifeng and Xiong, Liulin},
title = {Deep cervical lymphatic–venous anastomosis attenuates cognitive dysfunction and biomarker abnormalities in severe Alzheimer's disease: A prospective single‐arm study},
journal = {Alzheimer's & Dementia},
year = {2026},
volume = {22},
number = {2},
doi = {10.1002/alz.71150}
}
EUVIMED